Newsroom

The need for comprehensive testing seems obvious in the context of working up most cases of hematologic malignancies.

Esophageal cancer, while relatively uncommon, has risen dramatically over the past several decades.

The past decade has seen considerable diagnostic advances distinguishing classic Hodgkin lymphoma (CHL) from other lymphoma mimics.

Cancer claims more than half a million lives each year in the United States alone.